Whitehead B F, Stoehr C, Finkle C, Patterson G, Theodore J, Clayberger C, Starnes V A
Department of Cardiothoracic Surgery, Stanford University Medical Centre, California 94305, USA.
Respir Med. 1995 Jan;89(1):27-34. doi: 10.1016/0954-6111(95)90067-5.
Bronchoalveolar lavage (BAL) cells and peripheral blood leucocytes (PBL) from 24 lung transplant recipients were analysed for leucocyte subsets and expression of cell surface antigens. Total and differential white cell counts were performed on BAL, and lymphocyte subsets were evaluated in both BAL and peripheral blood. Measurement of immunofluorescence by flow cytometry was used to assess the percentage of: T cells (CD3+); T-helper cells (CD4+); T-cytotoxic/suppressor cells (CD8+); and activated lymphocytes (HLA-DR+). Lymphocyte subsets in BAL demonstrated marked differences to those in blood. A lower percentage of CD3+ and CD4+ lymphocytes were found in BAL, whereas CD8+ cells were more prevalent in BAL than in PBL. The mean CD4:CD8 ratio was significantly lower in BAL (1:1) than in blood (2.1:1). In the absence of pulmonary infection, there was a trend for a lower CD4:CD8 ratio in BAL associated with acute rejection (1.1:1) and obliterative bronchiolitis (1:1), when compared to the group with no evidence of rejection (1.4:1). In the absence of pulmonary rejection, pulmonary infection was associated with a marginally lower CD4:CD8 ratio in BAL (0.7:1), than when infection was absent (1.4:1). This difference was more evident in cases of cytomegalovirus (CMV) infection with a mean CD4:CD8 ratio of 0.3:1, compared to 1.5:1 in the absence of CMV disease (P < 0.05).
对24名肺移植受者的支气管肺泡灌洗(BAL)细胞和外周血白细胞(PBL)进行白细胞亚群和细胞表面抗原表达分析。对BAL进行全血细胞计数和分类计数,并对BAL和外周血中的淋巴细胞亚群进行评估。采用流式细胞术测量免疫荧光,以评估以下细胞的百分比:T细胞(CD3+);辅助性T细胞(CD4+);细胞毒性/抑制性T细胞(CD8+);以及活化淋巴细胞(HLA-DR+)。BAL中的淋巴细胞亚群与血液中的淋巴细胞亚群存在显著差异。在BAL中发现CD3+和CD4+淋巴细胞的百分比更低,而CD8+细胞在BAL中比在PBL中更普遍。BAL中的平均CD4:CD8比值(1:1)显著低于血液中的比值(2.1:1)。在没有肺部感染的情况下,与无排斥反应证据的组(1.4:1)相比,BAL中与急性排斥反应(1.1:1)和闭塞性细支气管炎(1:1)相关的CD4:CD8比值有降低的趋势。在没有肺部排斥反应的情况下,肺部感染与BAL中略低的CD4:CD8比值(0.7:1)相关,而在没有感染时该比值为(1.4:1)。与无巨细胞病毒(CMV)疾病时的平均CD4:CD8比值1.5:1相比,这种差异在CMV感染病例中更为明显,CMV感染时的平均CD4:CD8比值为0.3:1(P < 0.05)。